Literature DB >> 17243165

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.

Gopeshwar Narayan1, Veronique Bourdon, Seeta Chaganti, Hugo Arias-Pulido, Subhadra V Nandula, Pulivarthi H Rao, Lutz Gissmann, Matthias Dürst, Achim Schneider, Bhavana Pothuri, Mahesh Mansukhani, Katia Basso, R S K Chaganti, Vundavalli V Murty.   

Abstract

Cervical cancer (CC) cells exhibit complex karyotypic alterations, which is consistent with deregulation of numerous critical genes in its formation and progression. To characterize this karyotypic complexity at the molecular level, we used cDNA array comparative genomic hybridization (aCGH) to analyze 29 CC cases and identified a number of over represented and deleted genes. The aCGH analysis revealed at least 17 recurrent amplicons and six common regions of deletions. These regions contain several known tumor-associated genes, such as those involved in transcription, apoptosis, cytoskeletal remodeling, ion-transport, drug metabolism, and immune response. Using the fluorescence in situ hybridization (FISH) approach we demonstrated the presence of high-level amplifications at the 8q24.3, 11q22.2, and 20q13 regions in CC cell lines. To identify amplification-associated genes that correspond to focal amplicons, we examined one or more genes in each of the 17 amplicons by Affymetrix U133A expression arrays and semiquantitative reverse-transcription PCR (RT-PCR) in 31 CC tumors. This analysis exhibited frequent and robust upregulated expression in CC relative to normal cervix for genes EPHB2 (1p36), CDCA8 (1p34.3), AIM2 (1q22-23), RFC4, MUC4, and HRASLS (3q27-29), SKP2 (5p12-13), CENTD3 (5q31.3), PTK2, RECQL4 (8q24), MMP1 and MMP13 (11q22.2), AKT1 (14q32.3), ABCC3 (17q21-22), SMARCA4 (19p13.3) LIG1 (19q13.3), UBE2C (20q13.1), SMC1L1 (Xp11), KIF4A (Xq12), TMSNB (Xq22), and CSAG2 (Xq28). Thus, the gene dosage and expression profiles generated here have enabled the identification of focal amplicons characteristic for the CC genome and facilitated the validation of relevant genes in these amplicons. These data, thus, form an important step toward the identification of biologically relevant genes in CC pathogenesis. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17243165     DOI: 10.1002/gcc.20418

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  85 in total

1.  Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion.

Authors:  Adam Pickard; Ann-Christin Cichon; Anna Barry; Declan Kieran; Daksha Patel; Peter Hamilton; Manuel Salto-Tellez; Jacqueline James; Dennis J McCance
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

2.  Rothmund-Thomson Syndrome-like RECQL4 truncating mutations cause a haploinsufficient low bone mass phenotype in mice.

Authors:  Wilson Castillo-Tandazo; Ann E Frazier; Natalie A Sims; Monique F Smeets; Carl R Walkley
Journal:  Mol Cell Biol       Date:  2020-12-23       Impact factor: 4.272

Review 3.  Multifaceted regulation and functions of replication factor C family in human cancers.

Authors:  Yanling Li; Sijie Gan; Lin Ren; Long Yuan; Junlan Liu; Wei Wang; Xiaoyu Wang; Yi Zhang; Jun Jiang; Fan Zhang; Xiaowei Qi
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

4.  Human RecQL4 helicase plays critical roles in prostate carcinogenesis.

Authors:  Yanrong Su; Jarah A Meador; Gloria M Calaf; Luca Proietti De-Santis; Yongliang Zhao; Vilhelm A Bohr; Adayabalam S Balajee
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

5.  Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells.

Authors:  Can Dai; Cong-Xiu Miao; Xiao-Ming Xu; Lv-Jun Liu; Yi-Fan Gu; Di Zhou; Lian-Sheng Chen; Ge Lin; Guang-Xiu Lu
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

6.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

7.  Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1.

Authors:  Jacqueline Banyard; Courtney Barrows; Bruce R Zetter
Journal:  Genes Chromosomes Cancer       Date:  2009-06       Impact factor: 5.006

8.  Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls.

Authors:  Daniela Witten; Robert Tibshirani; Sam Guoping Gu; Andrew Fire; Weng-Onn Lui
Journal:  BMC Biol       Date:  2010-05-11       Impact factor: 7.431

9.  Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.

Authors:  Malin Lando; Marit Holden; Linn C Bergersen; Debbie H Svendsrud; Trond Stokke; Kolbein Sundfør; Ingrid K Glad; Gunnar B Kristensen; Heidi Lyng
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

10.  A 7 gene expression score predicts for radiation response in cancer cervix.

Authors:  Thangarajan Rajkumar; Neelakantan Vijayalakshmi; Kesavan Sabitha; Sundersingh Shirley; Ganesharaja Selvaluxmy; Mayil Vahanan Bose; Lavanya Nambaru
Journal:  BMC Cancer       Date:  2009-10-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.